4
Changes in Ownership
AGIOS PHARMACEUTICALS, INC. Filed Acc 0001439222-25-000118
Chief Medical Officer sold 2,454 shares at $43.78 ($107,436)
- Chief Medical Officer acquired 2,454 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Gheuens Sarah · Chief Medical Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2025-11-11 | Exercise or conversion : show line 1 in the form 10b5-1 | +2,454 | $25.01 | $61,375 | 64,181 | D |
| 2025-11-11 | Sale : show line 2 in the form 10b5-1 | −2,454 | $43.78 | $107,436 | 61,727 | D |
| Open-market sales · 2,454 sh · avg $43.78 · $107,436 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2025-11-11 | Exercise or conversion : show line 3 in the form 10b5-1 Stock options (right to buy) | −2,454 | 26,130 | D |
Loading xslF345X05/wk-form4_1763068136.xml…